Announcements Trials

Browse Landscape

Phase

Status

Terminated 3 Completed 2 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 42 Lung Neoplasms 13 Neoplasms 7 Brain Neoplasms 6 Pancreatic Neoplasms 3 Neoplasm Metastasis 3 NSCLC 3 Gastrointestinal Neoplasms 2 Esophageal Neoplasms 2 Central Nervous System Neoplasms 2 Breast Neoplasms 2 Adenocarcinoma, Bronchiolo-Alveolar 2 Adenocarcinoma of Lung 2 Tongue Neoplasms 1 Thoracic Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Respiratory Tract Diseases 1 Relapsed Pediatric Solid Tumor 1 Recurrence 1 Precancerous Conditions 1 Optic Nerve Glioma 1 Non-squamous Non-small Cell Lung Cancer 1 Metastatic Pancreatic Adenocarcinoma 1 Medulloblastoma 1 Lung Diseases 1 Head and Neck Neoplasms 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Familial ependymoma 1

Interventions

Cyclophosphamide 17 fludarabine 13 Dexamethasone 12 Cisplatin 12 Rituximab 10 Gemcitabine 9 Paclitaxel 8 Bendamustine Hydrochloride 8 Lenalidomide 7 Decitabine 7 Cytarabine 7 Carboplatin 7 fludarabine phosphate 6 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 6 Etoposide 6 Bortezomib 6 Radiotherapy 5 Injections 5 Azacitidine 5 camrelizumab 4 apatinib 4 Valproic Acid 4 Thalidomide 4 Procarbazine 4 Oxaliplatin 4 Drug Therapy 4 Bevacizumab 4 Antilymphocyte Serum 4 venetoclax 3 pomalidomide 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Recurrence × Erlotinib Hydrochloride × Clear all

NCT02015728 2016-12-15

SEED

Seattle Children's Hospital

Phase NA Unknown

Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡